Abstract Details

Title Assessment of the Anticonvulsant Effects and Tolerability Profile of Cannabidiol: GW Pharmaceuticals’ Preclinical Program

Topic Epilepsy/Clinical Neurophysiology (EEG)

Presentation(s) (-)

Poster/Presentation
Number 255

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
PRESENTER	No disclosure on file
David S. Goldstein, MD, PhD (National Institutes of Health)	Dr. Goldstein has received publishing royalties from a publication relating to health care.
	No disclosure on file
Thomas A. Hill, MD	No disclosure on file
	No disclosure on file
	No disclosure on file
Stephen Wright	No disclosure on file
	No disclosure on file
	No disclosure on file
Xiaoyang Lan, PhD	No disclosure on file

��ɫ��